Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of the Efficacy of Pyridostigmine for Reversal of Post Injection Dysphonia Following Botulinum Neurotoxin Laryngeal Chemo-Denervation in Spasmodic Dysphonia

NCT05110417 is registered in ClinicalTrials.gov with Eastern Virginia Medical School as lead sponsor.

NCT NCT05110417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05110417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of the Efficacy of Pyridostigmine for Reversal of Post Injection Dysphonia Following Botulinum Neurotoxin Laryngeal Chemo-Denervation in Spasmodic Dysphonia
Lead sponsor
Eastern Virginia Medical School
Phase
Phase 4
Overall status
Unknown status
Start date
May 20, 2021
Completion date
June 1, 2023
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysphonia, dysphonia, spastic, laryngeal dystonia